<p>In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh discusses stem cell therapy, and accessibility to and affordability of such treatment, with Rafael R Carazo Salas, founder and CEO of CellVoyant, an AI-first biotechnology company spun out from the University of Bristol.</p>

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh discusses stem cell therapy, and accessibility to and affordability of such treatment, with Rafael R Carazo Salas, founder and CEO of CellVoyant, an AI-first biotechnology company spun out from the University of Bristol.

Purity, potency, and safety – affordably – in stem cell therapy

pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.

Share Purity, potency, and safety – affordably – in stem cell therapy

Sign up to save your podcasts

Purity, potency, and safety – affordably – in stem cell therapy

Purity, potency, and safety – affordably – in stem cell therapy

More shows like pharmaphorum Podcast

Economist Podcasts

This Week in Microbiology

Pod Save America

The Daily

Up First from NPR

Pharmaceutical Executive

The Readout Loud

BioCentury This Week

Raising Health

Biotech Hangout